Herde Kevin 4
4 · MARAVAI LIFESCIENCES HOLDINGS, INC. · Filed May 2, 2024
Insider Transaction Report
Form 4
Herde Kevin
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2024-04-30$5.70/sh+1,780$10,146→ 334,694 total
Footnotes (1)
- [F1]The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,780 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.